Nanomedicine Market: Current Analysis and Forecast (2022-2028)
$3999 – $6999
Emphasis on Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, and Vaccines); Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Others); Region (North America, Europe, Asia-Pacific, Rest of the World); and Region/Country
The global nanomedicine market is expected to grow at a significant rate of around 10% during the forecast period. Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing, or actuation purposes in a living organism. The rising incidences of chronic diseases and the focus on the development of the nano-vaccine field is also a major contributor to the market growth of the market of nanomedicines. Furthermore, the rising prevalence of chronic diseases also has a significant share in the market growth of nanomedicines. For instance, as per the WHO, approximately 1.71 billion people have musculoskeletal conditions worldwide. Musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries.
Arrowhead Pharmaceuticals Inc., Brigham and Women’s Hospital, Nanospectra Biosciences Inc., ABLYNX, AMAG Pharmaceuticals, Bio-Gate AG, Celgene Corporation, Johnson & Johnson Inc., Pfizer Inc., and Abbott. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst product, Therapeutics category to witness higher CAGR during the forecast period”
Based on product, the market is segmented into therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines. The therapeutics category is to witness higher CAGR during the forecast period owing to the rising prevalence of the diseases and increasing cases of rare disorders. As per the Genetic and Rare Diseases Information Center, there are about 7,000 known rare diseases and collectively, about 1 in 10 people (or 30 million people) in the U.S. have a rare disease.
“Amongst application, the clinical oncology to hold a significant share in the market in 2021”
On the basis of application, the market is categorized into clinical oncology, infectious diseases, clinical cardiology, orthopedics, and others. Among these, clinical oncology to hold a significant share in the market in 2020. The rising number of cancer cases and the surging demand for disease-specific treatments is the major factor that increases the demand for nanomedicines in clinical oncology. For instance, as per the WHO, the cancer was leading cause of death in 2020, and cases of breast and lung cancer is accounted for 2.26 million and 2.21 million respectively.
“North America to hold a significant share in the market”
In 2020, North America held a significant share of the global nanomedicine market. This is mainly attributed to the rising number of product launches and the increasing investments in nanotechnology research in healthcare in the region. For instance, in July 2021, Jazz Pharmaceuticals plc announced the Health Canada approval and availability of Vyxeos® (daunorubicin and cytarabine liposome for injection) for the treatment of adults with newly diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Furthermore, the rising geriatric population in the region is also an important factor that increases the market size of nanomedicines in North America.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
The global Nanomedicine market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
You can also purchase parts of this report. Do you want to check out a section wise price list?
|2.1.||Research Process of the Nanomedicine Market|
|2.2.||Research Methodology of the Nanomedicine Market|
|5||IMPACT OF COVID-19 ON THE NANOMEDICINE MARKET|
|6||NANOMEDICINE MARKET REVENUE (USD BN), 2020-2028F|
|9.1.3.||Rest of North America|
|9.2.6.||Rest of Europe|
|9.3.4.||Rest of Asia-Pacific|
|9.4.||Rest of World|
|11||NANOMEDICINE MARKET OPPORTUNITIES|
|12||NANOMEDICINE MARKET TRENDS|
|13.1.||Demand Side Analysis|
|13.2.||Supply Side Analysis|
|14||VALUE CHAIN ANALYSIS|
|15.1.1.||Porters Fiver Forces Analysis|
|16.1.||Arrowhead Pharmaceuticals Inc.|
|16.2.||Brigham and Women’s Hospital|
|16.3.||Nanospectra Biosciences Inc.|
|16.8.||Johnson & Johnson Inc.|
Research Methodology for the Nanomedicine Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global nanomedicine market were the three major steps undertaken to create and analyze the adoption of nanomedicine in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global nanomedicine market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the nanomedicine market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the nanomedicine market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as product and application. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the nanomedicine market. Further, we conducted factor analysis using dependent and independent variables such as various products and applications of nanomedicine. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the nanomedicine market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global nanomedicine market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the nanomedicine market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global Nanomedicine market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global nanomedicine market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product and application in the global nanomedicine market.
The main objective of the Global Nanomedicine Market Study
The current & future market trends of the global nanomedicine market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the nanomedicine market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of product and
- Define and analysis of the regulatory framework for the nanomedicine
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the nanomedicine market for the major region.
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
- Company profiles of the nanomedicine market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry